Scpharmaceuticals Stock Forecast - Accumulation Distribution
| SCPH Stock | USD 3.60 0.19 5.57% |
Scpharmaceuticals Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Scpharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Scpharmaceuticals |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 3876.53 | 4921.6 |
| Check Scpharmaceuticals Volatility | Backtest Scpharmaceuticals | Trend Details |
Scpharmaceuticals Trading Date Momentum
| On September 03 2024 Scpharmaceuticals was traded for 4.95 at the closing time. The top price for the day was 5.17 and the lowest listed price was 4.88 . The trading volume for the day was 203.1 K. The trading history from September 3, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 2.75% . The trading price change against the current closing price is 2.36% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Scpharmaceuticals to competition |
Other Forecasting Options for Scpharmaceuticals
For every potential investor in Scpharmaceuticals, whether a beginner or expert, Scpharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Scpharmaceuticals Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Scpharmaceuticals. Basic forecasting techniques help filter out the noise by identifying Scpharmaceuticals' price trends.Scpharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scpharmaceuticals stock to make a market-neutral strategy. Peer analysis of Scpharmaceuticals could also be used in its relative valuation, which is a method of valuing Scpharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Scpharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Scpharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Scpharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Scpharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Scpharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Scpharmaceuticals shares will generate the highest return on investment. By undertsting and applying Scpharmaceuticals stock market strength indicators, traders can identify Scpharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 55616.81 | |||
| Daily Balance Of Power | 0.5588 | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 3.47 | |||
| Day Typical Price | 3.51 | |||
| Price Action Indicator | 0.23 | |||
| Period Momentum Indicator | 0.19 |
Scpharmaceuticals Risk Indicators
The analysis of Scpharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Scpharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting scpharmaceuticals stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.64 | |||
| Standard Deviation | 3.56 | |||
| Variance | 12.67 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Scpharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Scpharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Scpharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Scpharmaceuticals Stock:Check out Historical Fundamental Analysis of Scpharmaceuticals to cross-verify your projections. For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scpharmaceuticals. If investors know Scpharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scpharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.98) | Revenue Per Share 0.741 | Quarterly Revenue Growth 1.641 | Return On Assets (0.42) | Return On Equity (1.67) |
The market value of Scpharmaceuticals is measured differently than its book value, which is the value of Scpharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Scpharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Scpharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scpharmaceuticals' market value can be influenced by many factors that don't directly affect Scpharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scpharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scpharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scpharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.